In August, India’s Central Drugs Standard
Control Organisation (CDSCO) notified
all regional drug controllers that they
must better enforce requirements for Indian
manufacturers to submit quality data
for nonpatent and proprietary medicines.
CDSCO requires this data at the time of
submission. Data should show that drug
product is stable under storage conditions.